Inventiva (IVA) Revenue (2020 - 2025)
Inventiva (IVA) posted quarterly Revenue of $78277.6 for Q2 2021, down 3.96% year-over-year from $81508.0 in Q2 2020, and down 12.31% quarter-over-quarter from $89261.5 in Q1 2021.
Analysis
Inventiva (IVA) Revenue (2020 - 2025) Analysis & Trends
Inventiva's Revenue history runs 3 years deep, the most recent figure standing at $78277.6 for Q2 2021.
- In Q2 2021, Revenue fell 3.96% year-over-year to $78277.6; the TTM figure through Jun 2021 stood at $692579.0 (changed N/A YoY), while the FY2025 annual figure was $9.2 million, down 41.37% from the prior year.
- Revenue for Q2 2021 stood at $78277.6, down from $89261.5 in the prior quarter.
- The five-year high for Revenue was $7.7 million in Q4 2019, with the low at $78277.6 in Q2 2021.
- The 3-year median for Revenue is $92652.1 (2021), against an average of $1.4 million.
- The sharpest annual moves came in 2020 and 2021: Revenue tumbled 94.27% in 2020, then fell 3.96% in 2021.
- Inventiva's Revenue stood at $7.7 million in 2019, then sank by 94.27% to $443531.8 in 2020, then slumped by 82.35% to $78277.6 in 2021.
- Business Quant data shows IVA's Revenue at $78277.6 in Q2 2021, $89261.5 in Q1 2021, and $443531.8 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Inventiva | 886.37 Mn | 886.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -3.02 Mn |
| Jun 30, 2024 | 172,302.01 |
| Dec 31, 2022 | 3.87 Mn |
| Jun 30, 2022 | 313,714.67 |
| Jun 30, 2021 | 78,277.64 |
| Mar 31, 2021 | 89,261.47 |
| Jun 30, 2020 | 81,508.05 |
| Mar 31, 2020 | 96,042.70 |